Tavassoli F A
Department of Gynecologic and Breast Pathology, Armed Forces Institute of Pathology, Washington, D.C. 20306-6000.
Am J Surg Pathol. 1991 Jun;15(6):554-68. doi: 10.1097/00000478-199106000-00004.
The clinical and pathologic features of 31 breast lesions composed of a prominent proliferation of myoepithelial cells either admixed with epithelial cells or in pure form were studied. The lesions were divided into three categories: myoepitheliosis, adenomyoepithelioma, and malignant myoepithelioma (myoepithelial carcinoma); the latter is the only lesion composed purely of myoepithelial cells. Three multifocal, microscopic lesions located in the peripheral duct system were designated as myoepitheliosis. Twenty-seven solitary, grossly palpable, predominantly centrally located lesions qualified as adenomyoepithelioma. These were further subdivided into spindle-cell, tubular, and lobulated variants. Two lesions in the latter group had a carcinoma arising within them. Only one case, which was characterized by a solitary mass composed of an infiltrative spindle cell proliferation, qualified as malignant myoepithelioma (myoepithelial carcinoma). Two patients with adenomyoepithelioma developed recurrences; one tumor was of the tubular type, the other of the lobulated type. Both of these tumors had irregular margins. One of these patients had two recurrences and is currently well 8.5 years after the initial excision. The second patient developed a recurrence 8 months after initial excision; the recurrence presented as multiple nodules. One of the patients with myoepithelial carcinoma arising in an adenomyoepithelioma also developed a recurrence within 2.3 years. Her initial tumor was located in the axillary tail of the breast, and she had axillary node metastasis at the time of presentation. All remaining patients with follow-up are well without evidence of recurrence up to 17.3 years after the initial diagnosis (average follow-up, 6.1 years); one patient died of unrelated causes.
对31例乳腺病变进行了临床和病理特征研究,这些病变的肌上皮细胞显著增生,或与上皮细胞混合存在,或呈纯形式。病变分为三类:肌上皮增生症、腺肌上皮瘤和恶性肌上皮瘤(肌上皮癌);后者是唯一纯粹由肌上皮细胞组成的病变。位于外周导管系统的三个多灶性微小病变被定为肌上皮增生症。27个孤立的、可触及的、主要位于中央的病变符合腺肌上皮瘤的诊断标准。这些病变进一步细分为梭形细胞型、管状型和分叶型。后一组中有两个病变内发生了癌。只有一例以由浸润性梭形细胞增生构成的孤立肿块为特征,符合恶性肌上皮瘤(肌上皮癌)的诊断标准。两名腺肌上皮瘤患者出现复发;一例肿瘤为管状型,另一例为分叶型。这两个肿瘤的边缘均不规则。其中一名患者复发了两次,初次切除后8.5年目前情况良好。第二名患者初次切除后8个月出现复发;复发表现为多个结节。在腺肌上皮瘤中发生肌上皮癌的一名患者在2.3年内也出现了复发。她的初始肿瘤位于乳腺腋尾部,就诊时已有腋窝淋巴结转移。所有其余接受随访的患者在初次诊断后长达17.3年(平均随访6.1年)均情况良好,无复发迹象;一名患者死于无关原因。